Bionano Genomics Sees Q3 Sales $6.700M-$7.200M vs $7.661M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Bionano Genomics (NASDAQ:BNGO) sees Q3 sales of $6.700 million-$7.200 million vs $7.661 million analyst estimate.
Bionano Genomics (NASDAQ:BNGO) sees Q3 sales of $6.700 million-$7.200 million vs $7.661 million analyst estimate.